Articles with public access mandates - James TriccasLearn more
Not available anywhere: 13
Rifapentine-loaded PLGA microparticles for tuberculosis inhaled therapy: preparation and in vitro aerosol characterization
T Parumasivam, SSY Leung, DH Quan, JA Triccas, WJ Britton, HK Chan
European Journal of Pharmaceutical Sciences 88, 1-11, 2016
Mandates: Australian Research Council, National Health and Medical Research Council …
Antitubercular bis-substituted cyclam derivatives: Structure–activity relationships and in vivo studies
M Spain, JKH Wong, G Nagalingam, JM Batten, E Hortle, SH Oehlers, ...
Journal of Medicinal Chemistry 61 (8), 3595-3608, 2018
Mandates: National Health and Medical Research Council, Australia
Protective efficacy of recombinant BCG over-expressing protective, stage-specific antigens of Mycobacterium tuberculosis
C Counoupas, R Pinto, G Nagalingam, WJ Britton, JA Triccas
Vaccine 36 (19), 2619-2629, 2018
Mandates: National Health and Medical Research Council, Australia, European Commission
Deciphering protective immunity against tuberculosis: implications for vaccine development
C Counoupas, JA Triccas, WJ Britton
Expert Review of Vaccines 18 (4), 353-364, 2019
Mandates: National Health and Medical Research Council, Australia, European Commission
Structure–Activity Relationships of cyclo(l-Tyrosyl-l-tyrosine) Derivatives Binding to Mycobacterium tuberculosis CYP121: Iodinated Analogues Promote Shift to …
S Rajput, KJ McLean, H Poddar, IR Selvam, G Nagalingam, JA Triccas, ...
Journal of Medicinal Chemistry 62 (21), 9792-9805, 2019
Mandates: Australian Research Council, UK Biotechnology and Biological Sciences …
The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection
KA Prendergast, C Counoupas, L Leotta, C Eto, W Bitter, N Winter, ...
Vaccine 34 (23), 2608-2615, 2016
Mandates: National Health and Medical Research Council, Australia
Broad activity of diphenyleneiodonium analogues against Mycobacterium tuberculosis, malaria parasites and bacterial pathogens
N Nguyen, DW Wilson, G Nagalingam, JA Triccas, EK Schneider, J Li, ...
European Journal of Medicinal Chemistry 148, 507-518, 2018
Mandates: National Health and Medical Research Council, Australia
Cutinase-like protein-6 of Mycobacterium tuberculosis is recognised in tuberculosis patients and protects mice against pulmonary infection as a single and fusion protein vaccine
ER Shanahan, R Pinto, JA Triccas, WJ Britton, NP West
Vaccine 28 (5), 1341-1346, 2010
Mandates: US National Institutes of Health
Delivery of a multivalent scrambled antigen vaccine induces broad spectrum immunity and protection against tuberculosis
NP West, SA Thomson, JA Triccas, CJ Medveczky, IA Ramshaw, ...
Vaccine 29 (44), 7759-7765, 2011
Mandates: US National Institutes of Health
Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection
H Muflihah, M Flórido, LCW Lin, Y Xia, JA Triccas, J Stambas, WJ Britton
Vaccine 36 (18), 2462-2470, 2018
Mandates: National Health and Medical Research Council, Australia
TCR affinity controls the dynamics but not the functional specification of the antimycobacterial CD4+ T cell response
ND Bhattacharyya, C Counoupas, L Daniel, G Zhang, SJ Cook, ...
The Journal of Immunology 206 (12), 2875-2887, 2021
Mandates: National Health and Medical Research Council, Australia
Influence of phthiocerol dimycocerosate on CD4+ T cell priming and persistence during Mycobacterium tuberculosis infection
R Pinto, JK Nambiar, L Leotta, C Counoupas, WJ Britton, JA Triccas
Tuberculosis 99, 25-30, 2016
Mandates: National Health and Medical Research Council, Australia
An inducible expression system for high-level expression of recombinant proteins in slow growing mycobacteria
L Leotta, JM Spratt, CU Kong, JA Triccas
Plasmid 81, 27-31, 2015
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 83
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
DS Khoury, D Cromer, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ...
Nature medicine 27 (7), 1205-1211, 2021
Mandates: National Health and Medical Research Council, Australia, Medical Research …
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
D Cromer, M Steain, A Reynaldi, TE Schlub, AK Wheatley, JA Juno, ...
The Lancet Microbe 3 (1), e52-e61, 2022
Mandates: National Health and Medical Research Council, Australia, Medical Research …
Migratory dermal dendritic cells act as rapid sensors of protozoan parasites
LG Ng, A Hsu, MA Mandell, B Roediger, C Hoeller, P Mrass, ...
PLoS pathogens 4 (11), e1000222, 2008
Mandates: US National Institutes of Health
Animal and translational models of SARS-CoV-2 infection and COVID-19
MD Johansen, A Irving, X Montagutelli, MD Tate, I Rudloff, MF Nold, ...
Mucosal immunology 13 (6), 877-891, 2020
Mandates: National Health and Medical Research Council, Australia
Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
SJ Kent, DS Khoury, A Reynaldi, JA Juno, AK Wheatley, E Stadler, ...
Nature Reviews Immunology 22 (6), 387-397, 2022
Mandates: US National Institutes of Health, National Health and Medical Research …
New tuberculosis drug leads from naturally occurring compounds
D Quan, G Nagalingam, R Payne, JA Triccas
International Journal of Infectious Diseases 56, 212-220, 2017
Mandates: National Health and Medical Research Council, Australia
Correlates of protection, thresholds of protection, and immunobridging among persons with SARS-CoV-2 infection
DS Khoury, TE Schlub, D Cromer, M Steain, Y Fong, PB Gilbert, ...
Emerging Infectious Diseases 29 (2), 381, 2023
Mandates: US National Institutes of Health, National Health and Medical Research …
Publication and funding information is determined automatically by a computer program